echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > The regulatory role of small GTPases-Rab13 in breast cancer stem cells

    The regulatory role of small GTPases-Rab13 in breast cancer stem cells

    • Last Update: 2022-05-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The "seed" and "soil" theories are the basic theories of cancer stem cells


    Legend.


    On April 8, 2022 , Assistant Researcher Wang Hui from Jiao Baowei's research group published a research paper online entitled "Rab13 sustains breast cancer stem cells by supporting tumor-stroma crosstalk" in the Nature Index journal "Cancer Research"


    Researcher Jiao Baowei is the corresponding author of this work


    CD44 is a widely recognized breast cancer stem cell marker, and its splicing variant CD44v is diversely expressed in tumors and is closely associated with poor patient prognosis, but the splicing regulatory mechanism of CD44v production remains unclear


    The above work was completed under the funding of the National Key Research and Development Program, the National Natural Science Foundation of China, and the Yunnan Provincial Fund



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.